다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NYSE
Invitae Corporation (NVTA)
Invitae Corporation (NVTA) 뉴스

NVTA

Invitae (NVTA)

Invitae Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:NVTA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/06	22:31	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2024/02/07	07:07	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2024/01/30	21:00	PR Newswire (US)	Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics	NYSE:NVTA	Invitae Corporation
2024/01/30	06:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:NVTA	Invitae Corporation
2024/01/25	06:34	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NYSE:NVTA	Invitae Corporation
2024/01/22	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2024/01/22	21:00	PR Newswire (US)	Invitae Completes Sale of Reproductive Health Assets to Natera	NYSE:NVTA	Invitae Corporation
2024/01/19	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/12/22	11:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/12/22	11:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/12/15	06:29	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/12/14	06:07	PR Newswire (US)	Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts	NYSE:NVTA	Invitae Corporation
2023/12/12	06:41	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/11/18	06:48	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/11/16	06:22	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/11/15	09:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/11/15	09:55	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/11/09	06:36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:NVTA	Invitae Corporation
2023/11/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/11/09	06:01	PR Newswire (US)	Invitae Reports Third Quarter 2023 Financial Results	NYSE:NVTA	Invitae Corporation
2023/11/07	06:00	PR Newswire (US)	Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships	NYSE:NVTA	Invitae Corporation
2023/11/01	19:59	PR Newswire (US)	Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023	NYSE:NVTA	Invitae Corporation
2023/10/26	00:00	PR Newswire (US)	Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results	NYSE:NVTA	Invitae Corporation
2023/10/21	07:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation
2023/10/20	05:38	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:NVTA	Invitae Corporation
2023/10/20	05:30	PR Newswire (US)	Invitae Appoints Dr. David Sholehvar as Chief Operating Officer	NYSE:NVTA	Invitae Corporation
2023/10/13	05:15	PR Newswire (US)	Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast Cancer	NYSE:NVTA	Invitae Corporation
2023/10/11	05:30	PR Newswire (US)	Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics	NYSE:NVTA	Invitae Corporation
2023/10/04	01:07	PR Newswire (US)	Invitae's Common Hereditary Cancers Panel Receives FDA Market Authorization	NYSE:NVTA	Invitae Corporation
2023/10/03	10:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NVTA	Invitae Corporation

검색 관련기사 보기:NYSE:NVTA

1 2 3 4 5 6 7 8 9 10 다음 >>

Bank of America

American Express

Health Care Select Sector

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관